1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Subgroup analyses of a phase III trial comparing tivozanib hydrochloride versus sorafenib as initial targeted therapy for patients (pts) with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Hutson, T. E.; Nosov, D.; Eisen, T.; Lipatov, O. N.; Tomczak, P.; Alyasova, A.; Harza, M.; Kogan, M.; Alexseev, B. Y.; Szczylik, C.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • MicroRNA as novel blood-based biomarkers in clear cell renal cell carcinoma
    Meeting Abstract

    Hakimi, A. A.; Jacobsen, A.; Mikkilineni, N.; Fiegoli, B.; Blass, S.; Grigoryev, Y.; Viale, A.; Socci, N. D.; Voss, M. H.; Motzer, R. J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Global metabolic profiling of clear cell renal cell carcinoma
    Meeting Abstract

    Hakimi, A. A.; Lee, C. H.; Cross, J. R.; Li, Z.; Chen, Y.; Neri, B.; Reuter, V. E.; Motzer, R. J.; Russo, P.; Hsieh, J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Association of mutations in chromatin modifiers with poor survival in clear cell renal cell carcinoma: Analysis of the Cancer Genome Atlas Project
    Meeting Abstract

    Hakimi, A. A.; Ostrovnaya, I.; Voss, M. H.; Motzer, R. J.; Russo, P.; Reuter, V. E.; Hsieh, J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of paclitaxel, ifosfamide, and cisplatin (TIP) for previously untreated patients (pts) with intermediate- or poor-risk germ cell tumors (GCT)
    Meeting Abstract

    Feldman, D. R.; Hu, J.; Dorff, T. B.; Patil, S.; Van Alstine, L. J.; Momen, L.; Carousso, M.; Hughes, A.; Snively-Solomon, J.; Ketchens, C.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Enzalutamide in combination with docetaxel in men with prostate cancer (PC): Preliminary results from a phase I study
    Meeting Abstract

    Fleming, M. T.; Rathkopf, D. E.; Gibbons, J.; Peterson, A. C.; Hannah, A.; Forer, D.; Scher, H. I.; Morris, M. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Long-term responders to enzalutamide (ENZA) during the phase III AFFIRM trial: Baseline characteristics and efficacy outcomes
    Meeting Abstract

    Fleming, M. T.; Scher, H. I.; Fizazi, K.; Taplin, M. E.; Forer, D.; Hirmand, M.; De Bono, J. S.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Clinical-pathologic stage discrepancy in patients with bladder cancer treated with radical cystectomy: Associations with clinical variables and survival
    Meeting Abstract

    Gray, P. J.; Fedewa, S. A.; Shipley, W. U.; Lin, C. C.; Virgo, K. S.; Kibel, A. S.; Kamat, A. M.; Rosenberg, J. E.; Jemal, A.; Zietman, A. L.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Exploratory analysis of the visceral disease (VD) patient subset in COU-AA-301, a phase III study of abiraterone acetate (AA) in metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Goodman, O. B.; Flaig, T. W.; Molina, A.; Mulders, P.; Suttmann, H.; Li, J.; Kheoh, T. S.; De Bono, J. S.; Scher, H. I.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • mTOR inhibitor therapy for metastatic sarcomatoid clear cell renal cell carcinoma (ccRCC)
    Meeting Abstract

    Bastos, D. A.; Voss, M. H.; Karlo, C.; Ajeti, A.; Patil, S.; Feldman, D. R.; Molina, A. M.; Motzer, R. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save